What Research Mate Inc does

Research Mate Inc is a privately held clinical trial site management network headquartered in Humble, Texas. The company operates a multi-site network of clinical trial sites that conducts Phase I-IV studies on behalf of pharmaceutical and biotechnology sponsors across approximately 13 therapeutic areas, including Oncology, Diabetes, Cardiovascular, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Respiratory Diseases, Gastrointestinal Disorders, Dermatology, Ophthalmology, Psychiatry, Internal and Family Medicine, and Rheumatology.

The company positions itself as one of the largest private clinical trial networks in Texas, claiming 20+ years of operational experience and an exponentially expanding affiliate site base. Its go-to-market is enterprise B2B, selling site management services directly to pharma and biotech sponsors that require geographic coverage and patient recruitment capacity across multiple therapeutic indications. Revenue is generated through professional services fees tied to clinical trial execution at its network of sites.

Research Mate's stated strategic direction is to scale to 20+ owned investigation sites and extend operations into the European Union and Middle East. The company emphasizes access to patient populations in underserved communities as a recruitment differentiator for sponsors seeking diverse clinical trial enrollment.

Name

Research Mate Inc

Legal name

Research Mate

Website

https://clinicalresearchmate.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Research Mate Inc is a Texas-based private clinical trial site management network that conducts Phase I-IV studies across 13 therapeutic areas for pharmaceutical and biotechnology sponsors, operating an expanding multi-site affiliate network.

Ownership category

akta.pro rank

Product category

Clinical Trial Site Management Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE), Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)

Keywords

• Clinical trial services
• Site management
• Patient recruitment
• Pharmaceutical research
• Multi-therapeutic trials

Headquarters

HQ city

Humble

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Clinical Trial Site Management Services: Revenue generated from conducting clinical trials for pharmaceutical and biotech sponsors. Services include site selection, study initiation, patient recruitment, documentation, and data collection across Phase I-IV trials.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Research Mate Inc operates a private clinical trial site management network that conducts Phase I–IV clinical studies on behalf of pharmaceutical and biotechnology sponsors. Services span site selection, study initiation, patient recruitment (including diverse and underserved populations), documentation, and data collection across 13+ therapeutic areas through a network of owned and affiliate investigation sites in the United States.

Product overview

Research Mate Inc operates as a clinical trial site management platform offering comprehensive services for pharmaceutical and biotech companies. The company provides a unified platform of clinical trial services across 14 therapeutic areas (Oncology, Diabetes, Cardiovascular, Infectious Diseases, Neurological Disorders, Autoimmune Diseases, Respiratory Diseases, Gastrointestinal Disorders, Dermatology, Ophthalmology, Psychiatry, Internal and Family Medicine, and Rheumatology) with support for all four phases of clinical trials (Phase I Safety, Phase II Efficacy, Phase III Confirmation, Phase IV Post-Approval). The core Clinical Trial Site Management Services include quality services, accurate reporting, study posting, documentation, site selection, and study initiation. The company is positioned as one of the largest private clinical trial networks in Texas with expanding national footprint.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Site Management Services

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves1 record

Expansion highlights3 records

Broad incumbents

• PPD (Thermo Fisher Scientific): Global clinical research organization operating a site network (PPD sites and site management) for Phase I–IV trials across multiple therapeutic areas — direct overlap in clinical trial site management services offered to pharmaceutical sponsors.
• Syneos Health: Biopharmaceutical services organization offering clinical site management, patient recruitment, and full-service clinical operations for Phase I–IV — a direct competitor in the SMO/services category.
• ICON plc: Major global CRO with significant site management and clinical operations capabilities after PRA Health Sciences acquisition — directly comparable multi-therapeutic Phase I–IV service portfolio sold to pharma/biotech sponsors.
• IQVIA: Largest global CRO/SMO with a multi-therapeutic site network and site management services for pharmaceutical and biotech sponsors — the dominant incumbent in the exact category Research Mate competes in, but at vastly greater scale and with proprietary technology.
• Fortrea (LabCorp Drug Development spin-off): Global CRO with clinical trial site management services for pharma/biotech sponsors including full Phase I–IV conduct — competes directly with Research Mate for sponsor site-network engagements.

Direct peers

• Medpace: Mid-sized CRO with embedded site management and clinical operations expertise across multiple therapeutic areas — closest comparable in scale and operational model to a multi-therapeutic, sponsor-facing SMO/CRO like Research Mate.
• Worldwide Clinical Trials: Mid-sized CRO offering clinical trial management services across multiple therapeutic areas including neuroscience, cardiometabolic, oncology, and rare disease — comparable therapeutic breadth and sponsor target customer base to Research Mate.
• Velocity Clinical Research: Multi-therapeutic SMO operating owned and affiliated clinical trial sites for pharmaceutical and biotech sponsors across therapeutic areas including oncology, cardiology, neurology, and infectious disease — the most direct US SMO peer in scale and operating model.

Emerging players

• Clinipace Worldwide: Mid-market CRO/SMO offering multi-therapeutic clinical trial conduct and site management for biopharma sponsors — comparable in size tier and serves as a technology-augmented alternative to traditional SMO models.
• CliniOps: Technology-enabled clinical trial platform targeting site networks and sponsors with digital DCT and data capture tooling — relevant comparator for the decentralized/underserved-community thesis underlying Research Mate's network expansion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/research-mate

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Research Mate Inc